Coronavirus / COVID

Review of data in trial registries shows they specifically excluded this group from studies involving therapies.

Up to 40% more doses—or, enough to vaccinate another person with two doses—has been observed in the vials distributed at the beginning of this week.

Covaxx CEO Mei Mei Hu has seen vaccines from development all the way through to government approval. She offers her unique perspective into vaccine creation and an update on her company’s COVID-19 vaccine.

New research finds the rate of psychological distress among US adults remained more than 3 times higher than normal in the early months of the pandemic.

Host genetic variants associated with critical illness may identify mechanistic targets for therapeutic development.

UV light-emitting diodes are an emerging technology and a UV source for pathogen inactivation.

This non-prescription test allows users to perform and get results themselves without a medical provider or laboratory needed.

Data from three ongoing clinical studies were included in the EUA request.

A new study in JAMA recently evaluated and assessed the racial and ethnic disparities in hospitalizations and mortality across COVID-19 patients within New York City.

As Covid-19 infections soar across the U.S., states are again tightening restrictions and reinstituting lock down measures.

The virus is known to invade human cells through the ACE2 receptor-driven pathway, primarily impacting the respiratory tract.

While the number of study participants was too small to extrapolate for the whole population, the authors said they were encouraged.

Response to the COVID-19 pandemic has been hindered by lack of an effective antiviral therapy.

The findings are consistent with the hypothesis that bats are the viral origin and reservoir species.

A large family of viruses, coronaviruses include common cold viruses as well as more severe viruses.

The country's first authorized vaccine will be first available to healthcare workers and long-term care residents.

Detection of SARS-CoV-2 relies predominantly on nucleic acid testing and serological testing.

Mutations in TMEM41B are known to be common in one in five East Asians, but not in Europeans or Africans.

Despite early buzz, remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a failed to reduce mortality, hospital stays.

The VRBPAC committee voted 17-4, with 1 abstention, to support the benefit-risk profile of BNT162b2 for preventing COVID-19 in persons aged 16 years and older.

Many ocular symptoms are associated with the term ‘conjunctivitis’ which may be misleading.

New reports show COVID-19 reinfection is possible, but other data suggest many patients will likely be protected from reinfection for many months, or even years.

Pending investigations of 2 severe adverse events, people with a history of severe allergies are being advised by the UK’s regulatory agency not to get vaccinated.

Even as knowledge about SARS-COV-2 has considerably improved, several aspects remain unknown.

Just one day before the FDA meeting to discuss potential US authorization of the Pfizer and BioNtech vaccine, that country approves the vaccine.